HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wilhelm H Schmitt Selected Research

gusperimus

3/2011Treatment of active lupus nephritis with the novel immunosuppressant 15-deoxyspergualin: an open-label dose escalation study.
6/2005Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wilhelm H Schmitt Research Topics

Disease

7Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
03/2011 - 05/2002
6Systemic Vasculitis
04/2015 - 05/2002
4Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022 - 10/2004
4Vasculitis (Vasculitides)
08/2009 - 01/2003
3Brain Death (Brain Dead)
01/2019 - 12/2015
2Infections
06/2005 - 04/2004
2Churg-Strauss Syndrome (Allergic Angiitis)
01/2004 - 05/2002
1Sarcoidosis (Schaumann Disease)
03/2022
1Hypothermia
01/2019
1Neurologic Manifestations (Neurological Manifestations)
01/2016
1Acute Kidney Injury (Acute Renal Failure)
12/2015
1Proteinuria
03/2011
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2011
1Lupus Nephritis
03/2011
1Autoimmune Diseases (Autoimmune Disease)
11/2010
1Inflammation (Inflammations)
11/2010
1Leukocytosis (Pleocytosis)
01/2006
1Fever (Fevers)
01/2006
1Peritonitis
01/2006
1Microscopic Polyangiitis
01/2004
1Chronic Kidney Failure (Chronic Renal Failure)
01/2003

Drug/Important Bio-Agent (IBA)

5Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
08/2009 - 01/2003
2Dopamine (Intropin)FDA LinkGeneric
01/2019 - 03/2017
2gusperimusIBA
03/2011 - 06/2005
2C-Reactive ProteinIBA
11/2010 - 01/2006
2AutoantibodiesIBA
07/2006 - 05/2002
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2005 - 04/2004
1VaccinesIBA
03/2022
1Messenger RNA (mRNA)IBA
03/2022
1COVID-19 VaccinesIBA
01/2022
1BNT162 VaccineIBA
01/2022
1InterleukinsIBA
01/2016
1Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2016
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2015
1Estrogens (Estrogen)FDA Link
03/2011
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2011
1Pantoprazole (Protonix)FDA LinkGeneric
11/2010
1Pharmaceutical PreparationsIBA
11/2010
1Tretinoin (Retinoic Acid)FDA LinkGeneric
08/2009
1VitaminsIBA
08/2009
1Vitamin DFDA LinkGeneric
08/2009
1Retinoid X Receptor betaIBA
08/2009
1Adrenal Cortex Hormones (Corticosteroids)IBA
06/2005
1Peroxidase (Myeloperoxidase)IBA
10/2004
1SolutionsIBA
04/2004
1Thomsen-Friedenreich antibodiesIBA
04/2004
1Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
04/2004
1anti-endothelial cell antibodyIBA
05/2002
1Antigen-Antibody Complex (Immune Complex)IBA
05/2002
1VitronectinIBA
05/2002
1AntibodiesIBA
05/2002
1Fibronectins (Fibronectin)IBA
05/2002

Therapy/Procedure

3Therapeutics
04/2015 - 11/2010
2Kidney Transplantation
01/2019 - 12/2015
1Induced Hypothermia
01/2019
1Duration of Therapy
03/2017
1Transplantation
12/2015
1Aftercare (After-Treatment)
06/2005
1Organ Transplantation
01/2003